Future Trends in Smart Heterocyclic Drug Design
Corresponding author: [email protected]
Abstract
Heterocyclic compounds remain fundamental to modern drug discovery because of their structural diversity, broad biological activities and proven therapeutic value. The emergence of smart drug design has transformed conventional medicinal chemistry by integrating artificial intelligence, computational modeling, bioinformatics and advanced screening technologies to accelerate the discovery of safer and more effective therapeutics. This chapter explores recent developments in smart heterocyclic drug design, highlighting innovative strategies such as scaffold optimization, bioisosteric replacement, fragment-based drug design and multi-target drug development. It also discusses the growing role of nanotechnology, precision medicine and intelligent drug delivery systems in improving therapeutic specificity and clinical outcomes. Furthermore, sustainable synthetic approaches and green chemistry principles are presented as essential components of future pharmaceutical research. The chapter addresses current challenges, including drug resistance, toxicity, regulatory complexities and high development costs, while outlining future directions involving generative artificial intelligence, quantum computing and autonomous research platforms. Overall, smart heterocyclic drug design represents a multidisciplinary and technology-driven approach that has the potential to revolutionize pharmaceutical innovation by enabling the rapid development of personalized, effective and environmentally sustainable medicines.
Author Affiliations
- 1 Assistant Professor, Department of Pharmacology, KVPs Institute of Pharmaceutical Education, Boradi, Maharashtra, India.